Citations for
1MRD50, NAA10, NAA15
Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
Cheng H, Dharmadhikari AV, Varland S, Ma N, Domingo D, Kleyner R, Rope AF, Yoon M, Stray-Pedersen A, Posey JE, Crews SR, Eldomery MK, Akdemir ZC, Lewis AM, Sutton VR, Rosenfeld JA, Conboy E, Agre K, Xia F, Walkiewicz M, Longoni M, High FA, van Slegtenhorst MA, Mancini GMS, Finnila CR, van Haeringen A, den Hollander N, Ruivenkamp C, Naidu S, Mahida S, Palmer EE, Murray L, Lim D, Jayakar P, Parker MJ, Giusto S, Stracuzzi E, Romano C, Beighley JS, Bernier RA, Küry S, Nizon M, Corbett MA, Shaw M, Gardner A, Barnett C, Armstrong R, Kassahn KS, Van Dijck A, Vandeweyer G, Kleefstra T, Schieving J, Jongmans MJ, de Vries BBA, Pfundt R, Kerr B, Rojas SK, Boycott KM, Person R, Willaert R, Eichler EE, Kooy RF, Yang Y, Wu JC, Lupski JR, Arnesen T, Cooper GM, Chung WK, Gecz J, Stessman HAF, Meng L, Lyon GJ.
Am J Hum Genet 102(5):985-994. doi: 10.1016/j.ajhg.2018.03.004. Epub 2018 Apr 12. 2018
2NAA10, NTN1, UNC5B
Unc-5 homolog B (UNC5B) is one of the key downstream targets of N-α-Acetyltransferase 10 (Naa10).
Xu H, Han Y, Liu B, Li R.
Sci Rep 6:38508. doi: 10.1038/srep38508. 2016
3NAA10, NATD
Expanding the Phenotype Associated with NAA10-Related N-Terminal Acetylation Deficiency.
Saunier C, Støve SI, Popp B, Gérard B, Blenski M, AhMew N, de Bie C, Goldenberg P, Isidor B, Keren B, Leheup B, Lampert L, Mignot C, Tezcan K, Mancini GM, Nava C, Wasserstein M, Bruel AL, Thevenon J, Masurel A, Duffourd Y, Kuentz P, Huet F, Rivière JB, van Slegtenhorst M, Faivre L, Piton A, Reis A, Arnesen T, Thauvin-Robinet C, Zweier C.
Hum Mutat 37(8):755-64. doi: 10.1002/humu.23001. Epub 2016 May 4. 2016
4NAA10
The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine Residues.
Magin RS, March ZM, Marmorstein R.
J Biol Chem 291(10):5270-7. doi: 10.1074/jbc.M115.709428. Epub 2016 Jan 11. 2016
5NAA10, NATD
NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment.
Casey JP, Støve SI, McGorrian C, Galvin J, Blenski M, Dunne A, Ennis S, Brett F, King MD, Arnesen T, Lynch SA.
Sci Rep 5:16022. doi: 10.1038/srep16022. 2015
6NAA10, NATD
De novo missense mutations in the NAA10 gene cause severe non-syndromic developmental delay in males and females.
Popp B, Støve SI, Endele S, Myklebust LM, Hoyer J, Sticht H, Azzarello-Burri S, Rauch A, Arnesen T, Reis A.
Eur J Hum Genet 23(5):602-9. doi: 10.1038/ejhg.2014.150. Epub 2014 Aug 6. 2015
7NAA10
The biological functions of Naa10 - From amino-terminal acetylation to human disease.
Dörfel MJ, Lyon GJ.
Gene 567(2):103-31. doi: 10.1016/j.gene.2015.04.085. Epub 2015 May 16. Review. 2015
8NAA10, NATD
Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects.
Myklebust LM, Van Damme P, Støve SI, Dörfel MJ, Abboud A, Kalvik TV, Grauffel C, Jonckheere V, Wu Y, Swensen J, Kaasa H, Liszczak G, Marmorstein R, Reuter N, Lyon GJ, Gevaert K, Arnesen T.
Hum Mol Genet 24(7):1956-76. doi: 10.1093/hmg/ddu611. Epub 2014 Dec 8. 2015
9NAA10
Different subcellular localizations and functions of human ARD1 variants.
Seo JH, Park JH, Lee EJ, Kim KW.
Int J Oncol 46(2):701-7. doi: 10.3892/ijo.2014.2770. Epub 2014 Nov 21. 2015
10NAA10, RUNX2
NAA10 controls osteoblast differentiation and bone formation as a feedback regulator of Runx2.
Yoon H, Kim HL, Chun YS, Shin DH, Lee KH, Shin CS, Lee DY, Kim HH, Lee ZH, Ryoo HM, Lee MN, Oh GT, Park JW.
Nat Commun 5:5176. doi: 10.1038/ncomms6176. 2014
11NAA10
Nuclear translocation of hARD1 contributes to proper cell cycle progression.
Park JH, Seo JH, Wee HJ, Vo TT, Lee EJ, Choi H, Cha JH, Ahn BJ, Shin MW, Bae SJ, Kim KW.
PLoS One 9(8):e105185. doi: 10.1371/journal.pone.0105185. eCollection 2014. 2014
12NAA10, STAT5A
Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.
Zeng Y, Min L, Han Y, Meng L, Liu C, Xie Y, Dong B, Wang L, Jiang B, Xu H, Zhuang Q, Zhao C, Qu L, Shou C.
Carcinogenesis 35(10):2244-53. doi: 10.1093/carcin/bgu132. Epub 2014 Jun 12. 2014
13MCOPS1, NAA10
A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome.
Esmailpour T, Riazifar H, Liu L, Donkervoort S, Huang VH, Madaan S, Shoucri BM, Busch A, Wu J, Towbin A, Chadwick RB, Sequeira A, Vawter MP, Sun G, Johnston JJ, Biesecker LG, Kawaguchi R, Sun H, Kimonis V, Huang T.
J Med Genet 51(3):185-96. doi: 10.1136/jmedgenet-2013-101660. Epub 2014 Jan 15. 2014
14NAA10, PSME2
N-α-acetyltransferase 10 protein is a negative regulator of 28S proteasome through interaction with PA28β.
Min L, Xu H, Wang J, Qu L, Jiang B, Zeng Y, Meng L, Jin H, Shou C.
FEBS Lett 587(11):1630-7. doi: 10.1016/j.febslet.2013.04.016. Epub 2013 Apr 26. 2013
15NAA10, RIPK1
ARD1 binding to RIP1 mediates doxorubicin-induced NF-κB activation.
Park J, Kanayama A, Yamamoto K, Miyamoto Y.
Biochem Biophys Res Commun 422(2):291-7. doi: 10.1016/j.bbrc.2012.04.150. Epub 2012 May 3. 2012
16MCL1, NAA10, RELA
N-α-acetyltransferase 10 protein inhibits apoptosis through RelA/p65-regulated MCL1 expression.
Xu H, Jiang B, Meng L, Ren T, Zeng Y, Wu J, Qu L, Shou C.
Carcinogenesis 33(6):1193-202. doi: 10.1093/carcin/bgs144. Epub 2012 Apr 10. 2012
17DNMT1, NAA10
hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing.
Lee CF, Ou DS, Lee SB, Chang LH, Lin RK, Li YS, Upadhyay AK, Cheng X, Wang YC, Hsu HS, Hsiao M, Wu CW, Juan LJ.
J Clin Invest 120(8):2920-30. doi: 10.1172/JCI42275. Epub 2010 Jul 1. 2010
18NAA10
Correlation of expression of human arrest-defective-1 (hARD1) protein with breast cancer.
Yu M, Ma M, Huang C, Yang H, Lai J, Yan S, Li L, Xiang M, Tan D.
Cancer Invest 27(10):978-83. doi: 10.3109/07357900902769723. 2009
19IKBKB, NAA10
Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation.
Kuo HP, Lee DF, Xia W, Lai CC, Li LY, Hung MC.
Biochem Biophys Res Commun 389(1):156-61. doi: 10.1016/j.bbrc.2009.08.127. Epub 2009 Aug 28. 2009
20NAA10
Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin.
Lim JH, Chun YS, Park JW.
Cancer Res 68(13):5177-84. doi: 10.1158/0008-5472.CAN-07-6234. 2008
21CTTN, NAA10, NAA15
Tubedown associates with cortactin and controls permeability of retinal endothelial cells to albumin.
Paradis H, Islam T, Tucker S, Tao L, Koubi S, Gendron RL.
J Cell Sci 121(Pt 12):1965-72. doi: 10.1242/jcs.028597. Epub 2008 May 21. 2008
22NAA10, NAA11
Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.
Arnesen T, Betts MJ, Pendino F, Liberles DA, Anderson D, Caro J, Kong X, Varhaug JE, Lillehaug JR.
BMC Biochem 7:13. 2006
23ARHGAP4, AVPR2, DIR1, NAA10
Severe combined immunodeficiency associated with nephrogenic diabetes insipidus and a deletion in the Xq28 region.
Broides A, Ault BH, Arthus MF, Bichet DG, Conley ME.
Clin Immunol 120(2):147-55. Epub 2006 Jun 15. 2006
24NAA10
Characterization of the native and fibrillar conformation of the human Nalpha-acetyltransferase ARD1.
Sánchez-Puig N, Fersht AR.
Protein Sci 15(8):1968-76. Epub 2006 Jul 5. 2006
25NAA10, NAA15
Identification and characterization of the human ARD1-NATH protein acetyltransferase complex.
Arnesen T, Anderson D, Baldersheim C, Lanotte M, Varhaug JE, Lillehaug JR.
Biochem J 386(Pt 3):433-43. 2005
26ARHGAP4, HCFC1, NAA10, XESFBK
Isolation of new genes in distal Xq28 : transcriptional map and identification of a human homologue of the ARD1 N-acetyl transferase of saccharomyces cerevisiae.
Tribioli C, et al.
Hum Mol Genet 3 : 1061-1067. 1994